Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Bagó is a leading Latin American pharmaceutical conglomerate headquartered in Argentina, with a significant global presence in over 50 countries. Founded in 1934, the company specializes in the development, manufacturing, and commercialization of a wide range of therapeutic products, including small molecules and complex biologics. Its extensive portfolio spans diverse therapeutic areas such as cardiology, gastroenterology, neurology, and oncology, featuring over 480 products. The group operates numerous production plants and research centers, maintaining a strong focus on innovation and high-quality standards. Through its subsidiaries and strategic alliances, Grupo Bagó also plays a critical role in vaccine production and biotechnology in the Southern Cone.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Bagó.